GB0015562D0 - Heterocycles - Google Patents

Heterocycles

Info

Publication number
GB0015562D0
GB0015562D0 GBGB0015562.2A GB0015562A GB0015562D0 GB 0015562 D0 GB0015562 D0 GB 0015562D0 GB 0015562 A GB0015562 A GB 0015562A GB 0015562 D0 GB0015562 D0 GB 0015562D0
Authority
GB
United Kingdom
Prior art keywords
heterocycles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0015562.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0015562.2A priority Critical patent/GB0015562D0/en
Publication of GB0015562D0 publication Critical patent/GB0015562D0/en
Priority to DO2001000187A priority patent/DOP2001000187A/en
Priority to KR1020027017503A priority patent/KR20040002386A/en
Priority to OA1200200386A priority patent/OA12293A/en
Priority to CNA018116086A priority patent/CN1639121A/en
Priority to JP2002504223A priority patent/JP2004512263A/en
Priority to IL15342701A priority patent/IL153427A0/en
Priority to SK1717-2002A priority patent/SK17172002A3/en
Priority to CA002412188A priority patent/CA2412188A1/en
Priority to YU91802A priority patent/YU91802A/en
Priority to HU0301228A priority patent/HUP0301228A3/en
Priority to APAP/P/2002/002698A priority patent/AP2002002698A0/en
Priority to EP01936728A priority patent/EP1292574A1/en
Priority to PCT/IB2001/001035 priority patent/WO2001098267A1/en
Priority to CZ20023967A priority patent/CZ20023967A3/en
Priority to BR0111867-6A priority patent/BR0111867A/en
Priority to PL01365956A priority patent/PL365956A1/en
Priority to NZ523141A priority patent/NZ523141A/en
Priority to EA200201269A priority patent/EA005117B1/en
Priority to AU62591/01A priority patent/AU781837B2/en
Priority to MXPA02012878A priority patent/MXPA02012878A/en
Priority to DZ013368A priority patent/DZ3368A1/en
Priority to PA20018519401A priority patent/PA8519401A1/en
Priority to US09/883,567 priority patent/US20020025948A1/en
Priority to PE2001000604A priority patent/PE20020253A1/en
Priority to ARP010102957A priority patent/AR028969A1/en
Priority to UY26787A priority patent/UY26787A1/en
Priority to TNTNSN01094A priority patent/TNSN01094A1/en
Priority to UA20021210406A priority patent/UA73176C2/en
Priority to US10/117,886 priority patent/US20030207876A1/en
Priority to BG107329A priority patent/BG107329A/en
Priority to IS6637A priority patent/IS6637A/en
Priority to HR20020998A priority patent/HRP20020998A2/en
Priority to MA26955A priority patent/MA26915A1/en
Priority to ZA200210278A priority patent/ZA200210278B/en
Priority to NO20026168A priority patent/NO20026168L/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB0015562.2A 2000-06-23 2000-06-23 Heterocycles Ceased GB0015562D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles
DO2001000187A DOP2001000187A (en) 2000-06-23 2001-06-06 3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPY
DZ013368A DZ3368A1 (en) 2000-06-23 2001-06-07 3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR
PL01365956A PL365956A1 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
AU62591/01A AU781837B2 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
CNA018116086A CN1639121A (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
JP2002504223A JP2004512263A (en) 2000-06-23 2001-06-07 3-Azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
IL15342701A IL153427A0 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
SK1717-2002A SK17172002A3 (en) 2000-06-23 2001-06-07 Derivatives of 3-azabicyclo[3,1,0]hexane as ligands of opiate receptors
CA002412188A CA2412188A1 (en) 2000-06-23 2001-06-07 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy
YU91802A YU91802A (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0.) hexane derivatives having opioid receptor affinity
HU0301228A HUP0301228A3 (en) 2000-06-23 2001-06-07 3-azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity, process for their preparation and pharmaceutical compositions containing them
APAP/P/2002/002698A AP2002002698A0 (en) 2000-06-23 2001-06-07 3-Azabicyclo[3.1.0] hexane derivatives useful in therapy.
EP01936728A EP1292574A1 (en) 2000-06-23 2001-06-07 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
PCT/IB2001/001035 WO2001098267A1 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
CZ20023967A CZ20023967A3 (en) 2000-06-23 2001-06-07 3-Azabicyclo[3,1,0]hexane derivatives exhibiting affinity for opiate receptors
BR0111867-6A BR0111867A (en) 2000-06-23 2001-06-07 3-Azabicyclo (3.1.0) hexane derivatives showing opioid receptor affinity
KR1020027017503A KR20040002386A (en) 2000-06-23 2001-06-07 3-azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity
NZ523141A NZ523141A (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
EA200201269A EA005117B1 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0)hexane derivatives having opioid 3-receptor affinity
OA1200200386A OA12293A (en) 2000-06-23 2001-06-07 3-Azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity.
MXPA02012878A MXPA02012878A (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity.
PA20018519401A PA8519401A1 (en) 2000-06-23 2001-06-12 3-AZABICICLO DERIVATIVES (3.1.0) USEFUL HEXANE IN THERAPY
US09/883,567 US20020025948A1 (en) 2000-06-23 2001-06-18 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PE2001000604A PE20020253A1 (en) 2000-06-23 2001-06-21 3-AZABICYCLE DERIVATIVES [3.1.0] HEXANE AS LIGANDS OF OPIACEAN RECEPTORS
ARP010102957A AR028969A1 (en) 2000-06-23 2001-06-21 3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPY
UY26787A UY26787A1 (en) 2000-06-23 2001-06-21 3-AZABICICLO DERIVATIVES (3.1.0.) HEXANO USEFUL IN THERAPY
TNTNSN01094A TNSN01094A1 (en) 2000-06-23 2001-06-22 NEW 3-AZABICYCLO [3,1,0] HEXANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
UA20021210406A UA73176C2 (en) 2000-06-23 2001-07-06 3-azabicyclo(3.1.0)hexan derivatives having affinity to opioid receptor
US10/117,886 US20030207876A1 (en) 2000-06-23 2002-04-08 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
IS6637A IS6637A (en) 2000-06-23 2002-11-28 3-azabicyclo [3.1.0] hexane derivatives useful in treatment
BG107329A BG107329A (en) 2000-06-23 2002-11-28 3-azabicyclo(3.1.0) hexane derivatives having opioid receptor affinity
HR20020998A HRP20020998A2 (en) 2000-06-23 2002-12-12 3-azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity
MA26955A MA26915A1 (en) 2000-06-23 2002-12-16 3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS.
ZA200210278A ZA200210278B (en) 2000-06-23 2002-12-19 3-azabicyclo(3.1.0)hexane derivatives useful in therapy.
NO20026168A NO20026168L (en) 2000-06-23 2002-12-20 Hexane derivatives having opioid receptor affinity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles

Publications (1)

Publication Number Publication Date
GB0015562D0 true GB0015562D0 (en) 2000-08-16

Family

ID=9894368

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0015562.2A Ceased GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles

Country Status (34)

Country Link
EP (1) EP1292574A1 (en)
JP (1) JP2004512263A (en)
KR (1) KR20040002386A (en)
CN (1) CN1639121A (en)
AP (1) AP2002002698A0 (en)
AR (1) AR028969A1 (en)
AU (1) AU781837B2 (en)
BG (1) BG107329A (en)
BR (1) BR0111867A (en)
CA (1) CA2412188A1 (en)
CZ (1) CZ20023967A3 (en)
DO (1) DOP2001000187A (en)
DZ (1) DZ3368A1 (en)
EA (1) EA005117B1 (en)
GB (1) GB0015562D0 (en)
HR (1) HRP20020998A2 (en)
HU (1) HUP0301228A3 (en)
IL (1) IL153427A0 (en)
IS (1) IS6637A (en)
MA (1) MA26915A1 (en)
MX (1) MXPA02012878A (en)
NO (1) NO20026168L (en)
NZ (1) NZ523141A (en)
OA (1) OA12293A (en)
PA (1) PA8519401A1 (en)
PE (1) PE20020253A1 (en)
PL (1) PL365956A1 (en)
SK (1) SK17172002A3 (en)
TN (1) TNSN01094A1 (en)
UA (1) UA73176C2 (en)
UY (1) UY26787A1 (en)
WO (1) WO2001098267A1 (en)
YU (1) YU91802A (en)
ZA (1) ZA200210278B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20084300B (en) * 2001-10-22 2008-02-11 Pfizer Prod Inc 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
AU2003242527B2 (en) * 2002-05-17 2008-10-23 Tioga Pharmaceuticals, Inc. Use of compounds that are effective as selective opiate receptor modulators
DE10259245A1 (en) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivatives of asimadolin with covalently bound acids
JP4960217B2 (en) 2004-02-23 2012-06-27 グラクソ グループ リミテッド Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE484502T1 (en) * 2005-06-14 2010-10-15 Glaxo Group Ltd NEW CONNECTIONS
US8163927B2 (en) 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
CN101677997B (en) 2007-03-30 2012-05-09 泰奥加制药公司 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
TWI423801B (en) * 2007-08-27 2014-01-21 Theravance Inc 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
CA2936749C (en) 2010-06-11 2019-07-09 Joshua R. Giguere Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
US9133116B2 (en) 2010-09-28 2015-09-15 Panacea Biotec Ltd. Bicyclic compounds
ES2774349T3 (en) 2013-11-20 2020-07-20 Sanwa Kagaku Kenkyusho Co Derived from 3-azabicyclo [3.1.0] hexane and its use for medical purposes
US10392345B2 (en) 2015-05-20 2019-08-27 Sanwa Kagaku Kenkyusho Co., Ltd. Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
US11702408B2 (en) 2017-02-17 2023-07-18 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110352055A (en) 2017-03-02 2019-10-18 株式会社三和化学研究所 The therapeutic agent of alcohol use disorders
CN108250088B (en) * 2018-01-04 2020-10-30 四川之江高新材料股份有限公司 Preparation method of N, N, N '-trimethyl-N' -hydroxyethyl bisaminoethylether

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065230A (en) * 1959-03-16 1962-11-20 Burroughs Wellcome Co Azabicyclohexanes and method of preparing them
AR245933A1 (en) * 1987-04-16 1994-03-30 Lilly Co Eli Piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PE20001420A1 (en) * 1998-12-23 2000-12-18 Pfizer CCR5 MODULATORS

Also Published As

Publication number Publication date
CZ20023967A3 (en) 2004-02-18
WO2001098267A1 (en) 2001-12-27
ZA200210278B (en) 2003-12-19
UA73176C2 (en) 2005-06-15
AR028969A1 (en) 2003-05-28
KR20040002386A (en) 2004-01-07
TNSN01094A1 (en) 2005-11-10
HRP20020998A2 (en) 2004-02-29
MXPA02012878A (en) 2003-05-14
SK17172002A3 (en) 2004-09-08
NO20026168L (en) 2003-02-18
DOP2001000187A (en) 2002-03-30
YU91802A (en) 2006-05-25
AU781837B2 (en) 2005-06-16
HUP0301228A3 (en) 2005-08-29
HUP0301228A2 (en) 2003-08-28
PL365956A1 (en) 2005-01-24
CA2412188A1 (en) 2001-12-27
IS6637A (en) 2002-11-28
UY26787A1 (en) 2002-01-31
AP2002002698A0 (en) 2002-12-31
EA200201269A1 (en) 2003-06-26
BG107329A (en) 2003-07-31
WO2001098267A8 (en) 2003-02-27
NZ523141A (en) 2005-06-24
EP1292574A1 (en) 2003-03-19
NO20026168D0 (en) 2002-12-20
AU6259101A (en) 2002-01-02
PE20020253A1 (en) 2002-04-08
JP2004512263A (en) 2004-04-22
EA005117B1 (en) 2004-10-28
OA12293A (en) 2004-03-18
CN1639121A (en) 2005-07-13
BR0111867A (en) 2003-07-01
DZ3368A1 (en) 2001-12-27
PA8519401A1 (en) 2002-12-30
MA26915A1 (en) 2004-12-20
IL153427A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
DE60105852D1 (en) Fluidmischsystem
DE50112082D1 (en) Bulk-acoustic-wave-filter
AU3391801A (en) Pyridinylimidazoles
DE50104081D1 (en) Hydrolager
DE50105205D1 (en) Creatinin-biosensor
DE60114954D1 (en) Polytrimethylenterephthalatgarn
AU6803901A (en) Bis-arylsulfones
GB0015562D0 (en) Heterocycles
DE50112740D1 (en) Strangführungselement
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE50112014D1 (en) Stiftheizer
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50107703D1 (en) Creatininsensor-kalibration
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
AU7635401A (en) Hetaryl-substituted heterocycles
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114303D1 (en) Nsaugluftkanal
DE60114837D1 (en) Signalmessung
DE50114375D1 (en) Compound-reibungsvakuumpumpe
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50006446D1 (en) Otoplastik

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)